Food and Drug Administration for the treatment of injuries or other medical conditions
Companies entering the peptide market will need to go beyond current compounding requirements by clearly communicating risks, providing prominent safety and side effect warnings, implementing robust patient screening protocols, and steering consumers away from misleading peptide information circulating on social media, online forums, and unverified sellers
BPC 157 has strong angiogenic potential, it acts protectively on endothelium, prevents and reverses thrombus formation after abdominal aorta anastomosis, affects many central disturbances (i.e., dopamine and 5-HT system), the NO-system (either Larginine and L-NAME effects), endothelin, acts as a free radical scavenger (counteracting CCl4-, paracetamol-, diclofenac-injuries) and exhibits neuroprotective properties
Understanding what each molecule actually is provides the foundation for a fair comparison
During the lyophilization (freeze-drying) process, the peptide often forms a solid, compacted puck or disc at the bottom of the vial
